LON:AGY Allergy Therapeutics Interim Earnings Results & Report GBX 1.31 -0.14 (-9.86%) As of 09:55 AM Eastern Allergy Therapeutics reported Interim earnings on March 31, 2025. The company reported EPS of -GBX 0.23. Research:ProfileEarnings History Earnings Announcement Details QuarterInterimReport DateMarch 31, 2025TimeBefore Market Opens Allergy Therapeutics EPS ResultsActual EPS-GBX 0.23Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAllergy Therapeutics Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Allergy Therapeutics Interim Earnings FAQ Did Allergy Therapeutics beat earnings estimates for Interim? Allergy Therapeutics (LON:AGY) reported earnings of -GBX 0.23 per share for Interim. The report was announced on Monday, March 31, 2025. Allergy Therapeutics Earnings HeadlinesArkadian Strategic Metals, ACG, Pantheon Resources, Buccaneer Energy, IXICO, Allergy TherapeuticsNovember 17 at 5:01 AM | finance.yahoo.comAllergy Therapeutics plc Announces Board ResignationsNovember 17 at 5:01 AM | marketscreener.comMTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.November 17 at 1:00 AM | Base Camp Trading (Ad)Allergy Therapeutics to go privateNovember 17 at 5:01 AM | finance.yahoo.comAllergy Therapeutics plc Reports Earnings Results for the Full Year Ended June 30, 2026November 14 at 8:08 AM | marketscreener.comMAllergy Therapeutics Expands FY26 Loss To £50 Mln; Plans Transition To Privately Trading CompanyNovember 13, 2026 | rttnews.comSee More Allergy Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Allergy Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Allergy Therapeutics and other key companies, straight to your email. Email Address About Allergy TherapeuticsAllergy Therapeutics (LON:AGY) is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development. Formed in 1999 out of Smith Kline Beecham, Allergy Therapeutics is headquartered in Worthing, UK with more than 11,000m2 of state-of-the-art MHRA-approved manufacturing facilities and laboratories. The Group has achieved over 9% compound annual growth since formation and employs c.500 employees. View Allergy Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its YearThe Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to WatchTyson Foods' Earnings Beat Hides a Warning for Consumer Staples Dividend InvestorsMongoDB's Biggest Advantage May Be GitLab's Biggest WeaknessMicrosoft's Outage Barely Moved Its Stock, But a Bigger Risk May Be BuildingTyson Foods' 10% Surge Puts a Breakout in Sight, But Wall Street Remains CautiousOndas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog? Upcoming Earnings Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.